NR (Nicotinamide Riboside)
Research Reliability -
An NAD+ precursor one step closer to NAD+ than NMN, with the longest human clinical trial track record.
Appetite
Mood
Sleep
NR (Nicotinamide Riboside)
Description
Nicotinamide riboside converts to NAD+ via fewer enzymatic steps than NMN and was the first NAD+ precursor to receive GRAS (Generally Recognized As Safe) status and a patented, clinically studied form (Niagen). Human trials consistently show 40–90% increases in blood NAD+ levels at standard doses, with research exploring benefits for muscle function, vascular health, and metabolic markers in older adults. Some biohackers prefer NR over NMN for its cleaner regulatory history and superior intestinal absorption, since NMN must be dephosphorylated before crossing the gut wall while NR does not. Effects are typically subtle and cumulative rather than immediately noticeable.
Effects
First 2 weeks
subtle to none
Weeks 2–4
Long term
How It Feels
Like NMN, this is a quiet NAD+ precursor with little reliable felt effect. Any energy benefit is subtle and individual. Its appeal is mechanistic and long-term rather than something you notice day to day.
Evidence
Evidence Strength
Moderate (some human RCTs)
Caveats
NR reliably raises NAD+ levels in humans; evidence for downstream longevity or performance outcomes beyond biomarkers is still preliminary.
Usage
Commonly Referenced Starting Amount
250 mg/day
Commonly Referenced Amount
250–1,000 mg/day is common; a safety trial has tested up to 3,000 mg/day for 30 days without serious issues
Referenced Upper Limit
No formal upper limit has been established, and the safety data here is genuinely better than NMN's. The same honesty caveat applies, though: reliably raising NAD+ is well established, but human healthspan or lifespan outcomes are not
Onset
2–4 weeks
Biomarkers to Track
Subjective
(Daily)
Energy and mental clarity (1–10)
Exercise endurance and recovery
Sleep quality score
Objective
(Quarterly)
Whole blood NAD+ level (specialty test)
Fasting insulin and glucose
Resting heart rate variability (HRV)
Generally well tolerated, similar to NMN, and better studied for safety. Still a longevity-oriented bet.
Pregnant and breastfeeding women, and cancer patients should check first.
Expecting noticeable energy, and assuming it clearly outperforms plain niacinamide.
Disclaimer
This information is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.
Martens CR et al. (2018). Nature Communications, 9, 1286. RCT (NR and NAD+ levels/blood pressure in healthy middle-aged and older adults). PMID: 29599478. DOI: 10.1038/s41467-018-03421-7.
MORE SUPPLEMENTS LIKE THIS
